Authentification abonné
lvrea
Accueil Tous les numéros Volume 27 / Numéro 4 (Juillet 2018) Méd. Intensive Réa., 27 4 (2018) 317-323 Références
Accès gratuit
Numéro
Méd. Intensive Réa.
Volume 27, Numéro 4, Juillet 2018
Médecine interne et transversalité
Page(s) 317 - 323
Section Mise au point / Update
DOI https://doi.org/10.3166/rea-2018-0046
Publié en ligne 12 juin 2018
  • Fahey JL, Barth WF, Solomon A, (1965) Serum hyperviscosity syndrome. JAMA 192: 464–467 [CrossRef] [PubMed] [Google Scholar]
  • Gertz MA, Kyle RA, (1995) Hyperviscosity syndrome. J Intensive Care Med 10: 128–141 [CrossRef] [PubMed] [Google Scholar]
  • Zimmerman E, (1967) Automatic recording of viscosity changes with the Ostwald capillary viscometer. Anal Biochem 21: 81–85 [CrossRef] [PubMed] [Google Scholar]
  • Wells R, (1970) Syndromes of hyperviscosity. N Engl J Med 283: 183–186 [CrossRef] [PubMed] [Google Scholar]
  • Dumas G, Merceron S, Zafrani L, Canet E, Lemiale V, Kouatchet A, Azoulay E, (2015) Hyperviscosity syndrome. Rev Med Interne 36: 588–595 [CrossRef] [PubMed] [Google Scholar]
  • Perry MC, Hoagland HC, (1976) The hyperviscosity syndrome. JAMA 236: 392–393 [CrossRef] [PubMed] [Google Scholar]
  • Kwaan HC, (2013) Hyperviscosity in plasma cell dyscrasias. Clin Hemorheol Microcirc 55: 75–83 [Google Scholar]
  • Merci de fournir les auteurs]] (1971) Hyperviscosity syndrome. Br Med J 2: 184–185 [CrossRef] [PubMed] [Google Scholar]
  • Retamozo S, Brito-Zerón P, Bosch X, Stone JH, Ramos-Casals M, (2013) Cryoglobulinemic disease. Oncology (Williston Park, NY) 27: 1098–1105 (1110–1116) [Google Scholar]
  • Hernández-Molina G, Bermúdez-Bermejo P, (2017) Hyperviscosity in primary Sjögren’s syndrome: clinical implications. Int J Rheum Dis 20: 84–89 [CrossRef] [PubMed] [Google Scholar]
  • Hague RA, Eden OB, Yap PL, Mok JY, Rae P, (1990) Hyperviscosity in HIV infected children--a potential hazard during intravenous immunoglobulin therapy. Blut 61: 66–67 [CrossRef] [Google Scholar]
  • Merci de fournir les auteurs]] (2003) Hyperviscosity as a complication in a variety of disorders. Semin Thromb Hemost 29: 459–466 [CrossRef] [PubMed] [Google Scholar]
  • Adams BD, Baker R, Lopez JA, Spencer S, (2010) Myeloproliferative disorders and the hyperviscosity syndrome. Hematol Oncol Clin North Am 24: 585–602 [CrossRef] [PubMed] [Google Scholar]
  • Lo Presti R, Caracciolo C, Montana M, Barone R, Catania A, Caimi G, (2012) Erythrocyte deformability evaluated by laser diffractometry in polycythemia vera. Clin Hemorheol Microcirc 50: 189–192 [Google Scholar]
  • Porcu P, Cripe LD, Ng EW, Bhatia S, Danielson CM, Orazi A, McCarthy LJ, (2000) Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma 39: 1–18 [CrossRef] [PubMed] [Google Scholar]
  • Bartolucci P, Lionnet F, (2014) Chronic complications of sickle cell disease. Rev Prat 64: 1120–1126 [PubMed] [Google Scholar]
  • Menke MN, Feke GT, McMeel JW, Treon SP, (2009) Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström’s macroglobulinemia. Clin Lymphoma Myeloma 9: 100–103 [CrossRef] [PubMed] [Google Scholar]
  • Jo JT, Schiff D, (2017) Management of neuro-oncologic emergencies. In: Handbook of Clinical Neurology. Elsevier, pp 715–741 [PubMed] [Google Scholar]
  • Shenoy S, Shetty S, Lankala S, Anwer F, Yeager A, Adigopula S, (2017) Cardiovascular oncologic emergencies. Cardiology 138: 147–158 [CrossRef] [Google Scholar]
  • Stone MJ, Bogen SA, (2012) Evidence-based focused review of management of hyperviscosity syndrome. Blood 119: 2205–2208 [CrossRef] [PubMed] [Google Scholar]
  • Mehta J, Singhal S, (2003) Hyperviscosity syndrome in plasma cell dyscrasias. Semin Thromb Hemost 29: 467–471 [CrossRef] [PubMed] [Google Scholar]
  • Stone MJ, (2009) Waldenström’s macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia. Clin Lymphoma Myeloma 9: 97–99 [CrossRef] [PubMed] [Google Scholar]
  • Lewis MA, Hendrickson AW, Moynihan TJ, (2011) Oncologic emergencies: pathophysiology, presentation, diagnosis, and treatment. CA Cancer J Clin 61: 287–314 [PubMed] [Google Scholar]
  • Valbonesi M, Bruni R, (2000) Clinical application of therapeutic erythrocytapheresis (TEA). Transfus Sci 22: 183–194 [CrossRef] [PubMed] [Google Scholar]
  • Kalayoglu-Besisik S, (2018) The use of emergency apheresis in the management of plasma cell disorders. Transfus Apher Sci. doi: 10.1016/j.transci.2018.02.014 [PubMed] [Google Scholar]
  • Castillo JJ, Garcia-Sanz R, Hatjiharissi E, Kyle RA, Leleu X, McMaster M, Merlini G, Minnema MC, Morra E, Owen RG, Poulain S, Stone MJ, Tam C, Varettoni M, Dimopoulos MA, Treon SP, Kastritis E, (2016) Recommendations for the diagnosis and initial evaluation of patients with Waldenström macroglobulinaemia: a Task Force from the 8th International Workshop on Waldenström macroglobulinaemia. Br J Haematol 175: 77–86 [CrossRef] [PubMed] [Google Scholar]
  • Gurland HJ, Lysaght MJ, Samtleben W, Schmidt B, (1984) A comparison of centrifugal and membrane-based apheresis formats. Int J Artif Organs 7: 35–38 [CrossRef] [PubMed] [Google Scholar]
  • Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, Dunbar NM, Witt V, Wu Y, Shaz BH, (2016) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing Committee of the American Society for Apheresis: the Seventh Special Issue: therapeutic apheresis-guidelines 2016. J Clin Apher 31: 149–162 [PubMed] [Google Scholar]
  • Kaplan AA, (2013) Therapeutic plasma exchange: a technical and operational review: therapeutic plasma exchange. J Clin Apher 28: 3–10 [CrossRef] [PubMed] [Google Scholar]
  • Aqui N, O’Doherty U, (2014) Leukocytapheresis for the treatment of hyperleukocytosis secondary to acute leukemia. Hematology Am Soc Hematol Educ Program 2014: 457–460 [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.